Atlantic International Corp.
NASDAQ:ATLNMedical - Diagnostics & Research
-$0.10 today
- Market cap
- $73.17M
- Beta
- 0.71
- P/E (TTM)
- -0.6
- EPS (TTM)
- -$1.08
Volume 18.56M
Average 0.44M
ATLN Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Atlantic International Corp.NASDAQ: ATLN
Financing Cash Flow · Q4 FY2025 · quarter ended Dec 2025
Financing cash flow turns positive
Q4 FY2025 financing cash flow was $8.2M, compared with -$269.68K a year earlier. Trailing-twelve-month financing cash flow was $3.87M.
Context
- Financing cash flow amounted to 0.9% of revenue in FY2025, down 0.3 pp from a year earlier.
- Financing cash flow increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly financing cash flow holds near $8.2M or moves back toward the trailing-twelve-month quarterly average of $966.43K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 3.87M USD
- Year-over-year change
- -28.2%
- 4-year CAGR
- -24.7%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.87M | -28.2% |
| FY2024 | 2024-12-31 | 5.38M | -38.8% |
| FY2023 | 2023-12-31 | 8.79M | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 12M | — |
Financing Cash Flow vs competitors
How ATLN compares with its peers on the latest reported figures
- ATLN's LTM Dec 2025 financing cash flow of $3.87M is the 7th largest of the 8 companies compared; the peer median is $24.27M.
- Its year-over-year change of -28.2% is the 6th highest of 7, against a peer median of +186.1%.
- Financing cash flow amounts to 0.9% of revenue for ATLN, versus a peer median of 1242.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $321.16M | +191.5% | -4.1% | 17350.5% |
| LTM Mar 2026 | $180.48M | +300903.0% | +202.6% | 10116.9% | |
| LTM Mar 2026 | $109.5M | +6044.6% | -1.3% | — | |
| LTM Mar 2026 | $24.27M | — | -36.0% | 21.3% | |
IMDXInsight Molecular Diagnostics Inc. | LTM Mar 2026 | $24.21M | -50.6% | -7.8% | 1242.3% |
| LTM Mar 2026 | $11.3M | -7.2% | +457.4% | 7.4% | |
ATLNAtlantic International Corp. | LTM Dec 2025 | $3.87M | -28.2% | — | 0.9% |
| LTM Mar 2026 | $147K | +180.8% | -91.4% | — | |
| Peer median (excluding ATLN) | $24.27M | +186.1% | -4.1% | 1242.3% | |
Competitors are the stored peer set for ATLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (3.7M) | (4.09M) | (15.25M) | (135.48M) | (59.43M) |
| Depreciation & Amortization | 86.44K | 87.94K | 5.04M | 4.99M | 210.5K |
| Deferred Income Tax | 0 | 0 | (5.14M) | 5.24M | 0 |
| Stock-Based Compensation | 333.98K | 256.9K | 0 | 45.2M | 36.14M |
| Change in Working Capital | 119.96K | (155.38K) | 204.34K | 15.95M | 10.22M |
| Accounts Receivables | 73.85K | (15.54K) | (384.28K) | (9.92M) | 2.41M |
| Inventory | (21.14K) | (20.71K) | 0 | 0 | 0 |
| Accounts Payables | 9.52K | (248.93K) | 631.86K | 1.23M | 3.08M |
| Other Working Capital | 57.73K | 129.79K | (43.24K) | 24.64M | 4.72M |
| Other Non-Cash Items | 1.17M | 242.81K | 6.07M | 58.11M | 8.47M |
| Operating Cash Flow | (1.99M) | (3.66M) | (9.08M) | (5.99M) | (4.4M) |
| Capital Expenditures | (14.47K) | (40.02K) | (73.71K) | (73.46K) | (66.77K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (5.98M) | (4.01M) | (2.8M) | 0 | 0 |
| Sales of Investments | 0 | 5.88M | 6.92M | 0 | 0 |
| Other Investing Activities | 0 | 0 | (4.12M) | 0 | 0 |
| Investing Cash Flow | (5.99M) | 1.83M | (73.71K) | (73.46K) | (66.77K) |
| Debt Repayment | (187.89K) | 0 | 8.83M | (962.48K) | 3.87M |
| Common Stock Issued | 13.81M | 0 | 1.8M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.63M) | 0 | (1.84M) | 6.35M | 0 |
| Financing Cash Flow | 12M | 0 | 8.79M | 5.38M | 3.87M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 4.02M | (1.83M) | (363.23K) | (674.25K) | (597.54K) |
| Free Cash Flow | (2M) | (3.7M) | (9.16M) | (6.06M) | (4.46M) |
Atlantic International Corp.
NASDAQ:ATLN
Intrinsic Alpha fair value
Locked
Current Price
$0.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.